#ASCOAI

#ASCOAI: A new perspective from Eddy Saad, MD, MSc of Dana-Farber Cancer Institute, explores how synthetic real-world data can help accelerate clinical trials, improve efficiency, and support better-informed decisions, all while safeguarding patient privacy.
https://ow.ly/zkzg50YJR4E

🫁 #ASCOAI: With gaps in molecular testing rates, AI may expand access to clinical decision-making tools.
Deep-learning models detected EGFR, ALK, BRAF, MET alterations in lung cancer from H&E slides.
👨‍⚕️ Christian Rolfo, MD, PhD
🔗 https://ow.ly/VLQM50YhS7W